Miller LL - Search Results

1

Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine.

Kilbourn RG, Gross SS, Lodato RF, Adams J, Levi R, Miller LL, Lachman LB, Griffith OW. Kilbourn RG, et al. Among authors: miller ll. J Natl Cancer Inst. 1992 Jul 1;84(13):1008-16. doi: 10.1093/jnci/84.13.1008. J Natl Cancer Inst. 1992. PMID: 1376778

2

Phase II trial of interleukin 1 alpha and indomethacin in treatment of metastatic melanoma.

Janik JE, Miller LL, Longo DL, Powers GC, Urba WJ, Kopp WC, Gause BL, Curti BD, Fenton RG, Oppenheim JJ, Conlon KC, Holmlund JT, Sznol M, Sharfman WH, Steis RG, Creekmore SP, Alvord WG, Beauchamp AE, Smith JW 2nd. Janik JE, et al. Among authors: miller ll. J Natl Cancer Inst. 1996 Jan 3;88(1):44-9. doi: 10.1093/jnci/88.1.44. J Natl Cancer Inst. 1996. PMID: 8847725 Clinical Trial.

3

Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapy.

Meropol NJ, Miller LL, Korn EL, Braitman LE, MacDermott ML, Schuchter LM. Meropol NJ, et al. Among authors: miller ll. J Natl Cancer Inst. 1992 Aug 5;84(15):1201-3. doi: 10.1093/jnci/84.15.1201. J Natl Cancer Inst. 1992. PMID: 1378905 No abstract available.

4

A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma.

Rothenberg ML, Cox JV, DeVore RF, Hainsworth JD, Pazdur R, Rivkin SE, Macdonald JS, Geyer CE Jr, Sandbach J, Wolf DL, Mohrland JS, Elfring GL, Miller LL, Von Hoff DD. Rothenberg ML, et al. Among authors: miller ll. Cancer. 1999 Feb 15;85(4):786-95. Cancer. 1999. PMID: 10091755 Clinical Trial.

5

Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinoma.

Socinski MA, Sandler AB, Israel VK, Gillenwater HH, Miller LL, Locker PK, Antonellini A, Elfring GL, Natale RB. Socinski MA, et al. Among authors: miller ll. Cancer. 2002 Oct 1;95(7):1520-7. doi: 10.1002/cncr.10852. Cancer. 2002. PMID: 12237921 Free article. Clinical Trial.

6

Phase II study of adozelesin in untreated metastatic breast cancer.

Cristofanilli M, Bryan WJ, Miller LL, Chang AY, Gradishar WJ, Kufe DW, Hortobagyi GN. Cristofanilli M, et al. Among authors: miller ll. Anticancer Drugs. 1998 Oct;9(9):779-82. doi: 10.1097/00001813-199810000-00006. Anticancer Drugs. 1998. PMID: 9840723 Clinical Trial.

7

Irinotecan in the treatment of glioma patients: current and future studies of the North Central Cancer Treatment Group.

Buckner JC, Reid JM, Wright K, Kaufmann SH, Erlichman C, Ames M, Cha S, O'Fallon JR, Schaaf LJ, Miller LL. Buckner JC, et al. Among authors: miller ll. Cancer. 2003 May 1;97(9 Suppl):2352-8. doi: 10.1002/cncr.11304. Cancer. 2003. PMID: 12712456 Free article.

8

Phase I clinical and pharmacologic trial of intravenous estramustine phosphate.

Hudes G, Haas N, Yeslow G, Gillon T, Gunnarsson PO, Ellman M, Nordle O, Eriksson B, Miller L, Cisar L, Kopreski M, Viaro D, Hartley-Asp B. Hudes G, et al. J Clin Oncol. 2002 Feb 15;20(4):1115-27. doi: 10.1200/JCO.2002.20.4.1115. J Clin Oncol. 2002. PMID: 11844837 Clinical Trial.

9

Phase I and pharmacokinetic trial of oral irinotecan administered daily for 5 days every 3 weeks in patients with solid tumors.

Drengler RL, Kuhn JG, Schaaf LJ, Rodriguez GI, Villalona-Calero MA, Hammond LA, Stephenson JA Jr, Hodges S, Kraynak MA, Staton BA, Elfring GL, Locker PK, Miller LL, Von Hoff DD, Rothenberg ML. Drengler RL, et al. Among authors: miller ll. J Clin Oncol. 1999 Feb;17(2):685-96. doi: 10.1200/JCO.1999.17.2.685. J Clin Oncol. 1999. PMID: 10080615 Clinical Trial.

10

The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies.

Smith JW 2nd, Urba WJ, Curti BD, Elwood LJ, Steis RG, Janik JE, Sharfman WH, Miller LL, Fenton RG, Conlon KC, et al. Smith JW 2nd, et al. Among authors: miller ll. J Clin Oncol. 1992 Jul;10(7):1141-52. doi: 10.1200/JCO.1992.10.7.1141. J Clin Oncol. 1992. PMID: 1607919 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

414 results

Search Page

Filters